We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Neutrophil Motility Reveals Potential Sepsis Biomarker

By LabMedica International staff writers
Posted on 21 Dec 2014
Print article
Image: The microfluidic device for ascertaining neutrophil motility patterns (Photo courtesy of the BioMEMS Resource Center, Massachusetts General Hospital).
Image: The microfluidic device for ascertaining neutrophil motility patterns (Photo courtesy of the BioMEMS Resource Center, Massachusetts General Hospital).
The development of sepsis in patients with major burns may be predicted by abnormal motility patterns of white blood cells called neutrophils, measured through the microscopic channels of a novel device.

Since the symptoms of sepsis are similar to those of the systemic inflammation that occurs in almost every serious burn patient, diagnosing sepsis relies on culturing bacteria from the blood, a process that takes 12 to 24 hours.

Scientists and bioengineers at the Massachusetts General Hospital (Boston, MA, USA) took blood samples from patients with large thermal injuries admitted to the Massachusetts General Hospital (MGH). Enrolment criteria included burns covering at least 20% of total body surface area, age between 18 and 81, and included in the enrollment were both male and female, proportionally distributed among ethnic groups.

Neutrophils were isolated from whole blood by density gradient using the EasySep Human Neutrophil Kit (STEMCELL Technologies Inc.; Vancouver, BC, Canada). A microfluidic devise was assembled to generate chemical gradients in two simple steps performed at the beginning of the study, after which the device does not require any user intervention or external syringe pumps to operate. The microfluidic devices was made with two layers of photoresist SU8 (Microchem; Newton, MA, USA), the first one 3 µm thin and the second one 50 µm thick, were patterned on one silicon wafer by sequentially employing two photolithography masks and processing cycles. The wafer with patterned photoresist was used as a mold to produce polydimethylsiloxane parts, which were then bonded irreversibly to standard glass slides.

The team analyzed the ability of neutrophils from blood samples of 13 patients with serious burns, collected several times during their treatment, to move through the device when it was primed with one of two chemical attractants or with saline solution, and compared it with the movement of cells from three healthy volunteers. Neutrophils from healthy individuals moved quickly and efficiently through the device toward a chemical attractant, easily navigating around corners and posts, while cells from burn patients showed limited, slower and poorly organized movement toward the chemical signal. This movement of neutrophils in the absence of chemical signals was observed in samples taken from some patients several days before a diagnosis of sepsis could be made, and once effective antibiotic treatment began, the unusual movement pattern began to fade.

Daniel Irimia, MD, PhD, a leading author of the study said, “Since only a handful of rare genetic disorders affect neutrophil function, it has long been assumed that studying these cells was not important; but our findings indicate that neutrophils play a much more important role in sepsis than has been appreciated. We're also working to expand this investigation to other patients at risk for sepsis, to see if the findings from burn patients have broader application.” The study was published on December 9, 2014, in the journal Public Library of Science ONE.

Massachusetts General Hospital
STEMCELL Technologies Inc. 
Microchem

Related Links:
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.